HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 2 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,251 | +263.9% | 2,571 | +290.7% | 0.00% | +200.0% |
| Q2 2023 | $23,155 | +13131.4% | 658 | -87.7% | 0.00% | -83.3% |
| Q1 2023 | $175 | +1150.0% | 5,367 | +1895.2% | 0.01% | +500.0% |
| Q4 2022 | $14 | -100.0% | 269 | -86.1% | 0.00% | 0.0% |
| Q3 2022 | $86,000 | +26.5% | 1,938 | +39.5% | 0.00% | -50.0% |
| Q2 2022 | $68,000 | +385.7% | 1,389 | +394.3% | 0.00% | – |
| Q1 2022 | $14,000 | -33.3% | 281 | -41.9% | 0.00% | – |
| Q4 2021 | $21,000 | +23.5% | 484 | +8.5% | 0.00% | – |
| Q3 2021 | $17,000 | -64.6% | 446 | -73.9% | 0.00% | -100.0% |
| Q2 2021 | $48,000 | +182.4% | 1,712 | +233.1% | 0.00% | – |
| Q1 2021 | $17,000 | +142.9% | 514 | +149.5% | 0.00% | – |
| Q4 2020 | $7,000 | -93.6% | 206 | -93.6% | 0.00% | -100.0% |
| Q3 2020 | $110,000 | – | 3,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $496,847,000 | 95.45% |
| Vivo Capital, LLC | 3,400,261 | $150,598,000 | 16.63% |
| Nan Fung Group Holdings Ltd | 510,978 | $22,631,000 | 14.44% |
| venBio Partners LLC | 1,125,673 | $49,856,000 | 11.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $11,715,000 | 3.76% |
| ASHFORD CAPITAL MANAGEMENT INC | 490,768 | $21,736,000 | 3.32% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,485 | $28,190,000 | 2.79% |
| Octagon Capital Advisors LP | 243,500 | $10,785,000 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 310,000 | $13,730,000 | 1.68% |
| Lisanti Capital Growth, LLC | 248,070 | $10,987,000 | 1.47% |